Levocetirizine 2.5 mg + Montelukast 4 mg Film-Coated Tablet

Levocetirizine 2.5 mg + Montelukast 4 mg Film-Coated Tablet is a film-coated tablet formulated with Levocetirizine 2.5 mg + Montelukast 4 mg. The active ingredient profile is Levocetirizine; Montelukast, placing the product in the antihistamine + leukotriene receptor antagonist combination category. Levocetirizine is an antihistamine and Montelukast is a leukotriene-receptor antagonist, a combination used in selected allergy-related settings where approved. The film coating provides a finished oral solid-dosage presentation and may support handling, stability and product acceptability. For website cataloguing, composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. The description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and the prescriber’s judgement. Prescription status, precautions, interactions, adverse effects and dosing must be checked against the current approved product label before publication. Manufacturer, licence, storage, shelf-life, pack configuration and market-specific regulatory details should be added only from verified product documentation.